WEGOVY (semaglutide) injection 2.4 mg is an injectable prescription medicine used with a reduced calorie diet and increased physical activity to treat adults with metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis), but not with cirrhosis of the liver This indication is approved based on improvement of MASH and liver scarring (fibrosis)
Meals should have a mix of protein, fiber and healthy fat
It may be related to decreased collagen turnover and reduced production of the precursor proteins from which GHK is naturally released
Lerche S, Brock B, Rungby J, et al
These studies generally show that the flu shot is safe and effective for people taking semaglutide
Si bien su perfil de eficacia y seguridad es comparable al Wegovy oral, se queda a aos luz de la tirzepatida subcutnea de Eli Lilly el estndar de oro de los anlogos de GLP-1 hasta la fecha (tcnicamente un doble agonista que imita tanto al GLP-1 como al GIP)
